China Universal Asset Management Co., Ltd. Ironwood Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 30,091 shares of IRWD stock, worth $183,856. This represents 0.03% of its overall portfolio holdings.
Number of Shares
30,091
Previous 30,091
-0.0%
Holding current value
$183,856
Previous $262,000
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$119 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$100 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$85 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$44 Million0.16% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $936M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...